Skip to main content
Danielle Golovin on Muck Rack

Danielle Golovin

Florida
As seen in: BioCentury, Zephyrnet
I love science, art, education, animals, board games, cooking and volleyball. Central Michigan (B.S.) and Vanderbilt University (Ph.D.) alum.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Danielle

Contact Danielle, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Science Spotlight: Actionable pathways for cachexia and radioresistance in lung cancer

|
By Danielle Golovin
| BioCentury Verified
ARTICLE | Discovery & Translation BioCentury’s translational roundup also includes a muscle-specific PROTAC platform and a dual tumor and TME-targeting CAR T therapy for glioblastoma By Danielle Golovin, Senior Biopharma Analyst Two recent papers identify new levers for drug developers in lung cancer: one for systemic symptoms, and one for treatment resistance.
Open in Who Shared Issue with article?

Race to cure HBV moves to targeting the reservoir

|
By Danielle Golovin
| BioCentury Verified
ARTICLE | Product Development Precision cuts HBV cccDNA while Tune and nChroma aim to shut it down with CRISPR‑based epigenetic silencers By Danielle Golovin, Senior Biopharma Analyst There’s now compelling evidence that eliminating viral transcripts with antisense oligonucleotides can lead to a functional HBV cure in some patients, and early clinical data from in vivo gene editing and epigenetic silencing therapies suggest that directly targeting the viral DNA reservoir could take that...
Open in Who Shared Issue with article?

Atlas Insights: Targetable directions in Parkinson’s disease

|
By Danielle Golovin
| BioCentury Verified
ARTICLE | Discovery & Translation Single-cell Parkinson’s atlases reveal neuronal and glial disruptions in specific regions and stages By Danielle Golovin, Senior Biopharma Analyst Single‑cell and multi‑omic Parkinson’s disease atlases are turning scattered genetic and immunological clues into insights that could serve as druggable cell states and pathways.
Open in Who Shared Issue with article?
See all 441 articles